Cybersecurity & Digital Identity Platform | $9.45M Rev | $1.62M EBITDA
20-Yr Platform | 4 Patented SW Products | $2.24M ARR @ 78% GM
Cash Flow: View Profit
New & First Device Treatment for Common Disorder Fibromyalgia
Financing Available
Cash Flow: View Profit

$1,200,000
View Profit
$1,200,000
View Profit





